CCIPD faculty awarded patent

Friday, January 31, 2020 - 09:00

Anant Madabhushi, PhD and Rakesh Shiradkar, PhD of the Center for Computational Imaging and Personalized Diagnostics and their collaborator Soumya Ghose, PhD were awarded the patent, "Predicting prostate cancer recurrence in pre-treatment prostate magnetic resonance imaging (MRI) with combined tumor induced organ distension and tumor radiomics”.

USSN: 10,540,570; January 21, 2020

Inventors: Anant Madabhushi, Rakesh Shiradkar, Soumya Ghose

Abstract: Embodiments predict prostate cancer (PCa) biochemical recurrence (BCR) employing an image acquisition circuit that accesses a first pre-treatment image and a second pre-treatment image of a region of tissue demonstrating PCa, a distension feature circuit that extracts a set of distension features from the first pre-treatment image, and computes a first probability of PCa BCR based on the set of distension features, a radiomics circuit that extracts a set of radiomics features from the second pre-treatment image, and computes a second probability of PCa recurrence based on the set of radiomics feature, a combined tumor induced organ distension with tumor radiomics (COnTRa) circuit that computes a joint probability that the region of tissue will experience PCa BCR based on the first probability and the second probability, and a display circuit that displays the joint probability.

Learn more about “Predicting prostate cancer recurrence in pre-treatment prostate magnetic resonance imaging (MRI) with combined tumor induced organ distension and tumor radiomics”.